Ken H. Ho

1.0k total citations
9 papers, 667 citations indexed

About

Ken H. Ho is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Ken H. Ho has authored 9 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 3 papers in Toxicology. Recurrent topics in Ken H. Ho's work include Neuroscience and Neuropharmacology Research (8 papers), Ion channel regulation and function (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Ken H. Ho is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Ion channel regulation and function (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Ken H. Ho collaborates with scholars based in United States, United Kingdom and Spain. Ken H. Ho's co-authors include David Bleakman, Paul L. Ornstein, Ann Marie L. Ogden, Mary Gates, Zuner A. Bortolotto, Ilse Smolders, Vernon R. J. Clarke, David Lodge, Graham L. Collingridge and Peter Miu and has published in prestigious journals such as Nature, Nature Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Ken H. Ho

9 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken H. Ho United States	9	544	389	142	52	52	9	667
Lorrie P. Daggett United States	20	917 1.7×	694 1.8×	174 1.2×	37 0.7×	53 1.0×	25	1.1k
Ann Marie L. Ogden United States	13	568 1.0×	429 1.1×	166 1.2×	121 2.3×	61 1.2×	17	846
Mark W. Irvine United Kingdom	15	556 1.0×	458 1.2×	157 1.1×	73 1.4×	51 1.0×	22	802
В. Е. Гмиро Russia	14	650 1.2×	569 1.5×	77 0.5×	43 0.8×	37 0.7×	97	814
Martin B. Gill United States	13	428 0.8×	395 1.0×	60 0.4×	71 1.4×	51 1.0×	18	612
Darryle D. Schoepp United States	14	893 1.6×	624 1.6×	161 1.1×	36 0.7×	85 1.6×	17	1.1k
Maryann Burno United States	7	659 1.2×	499 1.3×	124 0.9×	26 0.5×	22 0.4×	7	773
C Bain United Kingdom	8	991 1.8×	755 1.9×	133 0.9×	44 0.8×	107 2.1×	8	1.1k
И. Н. Шаронова Russia	15	404 0.7×	419 1.1×	117 0.8×	21 0.4×	32 0.6×	38	759
Allan Mandelzys Canada	13	792 1.5×	848 2.2×	145 1.0×	69 1.3×	75 1.4×	14	1.2k

Countries citing papers authored by Ken H. Ho

Since Specialization

Citations

This map shows the geographic impact of Ken H. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken H. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken H. Ho more than expected).

Fields of papers citing papers by Ken H. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken H. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken H. Ho. The network helps show where Ken H. Ho may publish in the future.

Co-authorship network of co-authors of Ken H. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Ken H. Ho. A scholar is included among the top collaborators of Ken H. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken H. Ho. Ken H. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Zarrinmayeh, Hamideh, Dennis M. Zimmerman, Nancy B. Rankl, et al.. (2006). A novel class of positive allosteric modulators of AMPA receptors: Design, synthesis, and structure–activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346. Bioorganic & Medicinal Chemistry Letters. 16(19). 5203–5206. 8 indexed citations

Alt, Andrew, et al.. (2004). Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro. Neuropharmacology. 46(6). 793–806. 88 indexed citations

Shepherd, Timothy A., James Aikins, David Bleakman, et al.. (2002). Design and Synthesis of a Novel Series of 1,2-Disubstituted Cyclopentanes as Small, Potent Potentiators of 2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic Acid (AMPA) Receptors. Journal of Medicinal Chemistry. 45(10). 2101–2111. 29 indexed citations

Smolders, Ilse, Zuner A. Bortolotto, Vernon R. J. Clarke, et al.. (2002). Antagonists of GLUK5-containing kainate receptors prevent pilocarpine-induced limbic seizures. Nature Neuroscience. 5(8). 796–804. 124 indexed citations

Miu, Peter, Keith R. Jarvie, Mary Gates, et al.. (2001). Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro. Neuropharmacology. 40(8). 976–983. 63 indexed citations

Bortolotto, Zuner A., Vernon R. J. Clarke, Michael C. Parry, et al.. (2001). A one-hit model of cell death in inherited neuronal degenerations. 9 indexed citations

Baker, Stephen, David Bleakman, Jesús Ezquerra, et al.. (2000). 4-Alkylidenyl glutamic acids, potent and selective GluR5 agonists. Bioorganic & Medicinal Chemistry Letters. 10(16). 1807–1810. 19 indexed citations

Ornstein, Paul L., Dennis M. Zimmerman, M. Brian Arnold, et al.. (2000). Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors. Journal of Medicinal Chemistry. 43(23). 4354–4358. 62 indexed citations

Bortolotto, Zuner A., Vernon R. J. Clarke, Michael C. Parry, et al.. (1999). Kainate receptors are involved in synaptic plasticity. Nature. 402(6759). 297–301. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact